Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21616285rdf:typepubmed:Citationlld:pubmed
pubmed-article:21616285lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21616285lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21616285lifeskim:mentionsumls-concept:C0085612lld:lifeskim
pubmed-article:21616285lifeskim:mentionsumls-concept:C0016229lld:lifeskim
pubmed-article:21616285lifeskim:mentionsumls-concept:C1631597lld:lifeskim
pubmed-article:21616285lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:21616285pubmed:issue22lld:pubmed
pubmed-article:21616285pubmed:dateCreated2011-5-27lld:pubmed
pubmed-article:21616285pubmed:abstractTextThis study evaluated the efficacy and safety of flecainide in addition to conventional drug therapy in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).lld:pubmed
pubmed-article:21616285pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:languageenglld:pubmed
pubmed-article:21616285pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21616285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21616285pubmed:statusMEDLINElld:pubmed
pubmed-article:21616285pubmed:monthMaylld:pubmed
pubmed-article:21616285pubmed:issn1558-3597lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:WatanabeHiros...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:ShimizuWataru...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:WildeArthur...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:HaïssaguerreM...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:LeenhardtAnto...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:KrahnAndrew...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:SumitomoNaoka...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:ViskinSamiSlld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:KannankerilPr...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:KnollmannBjör...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:BhuiyanZahuru...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:FishFrank AFAlld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:SacherFrederi...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:LaborderieJul...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:WillemsAlbert...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:21616285pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:21616285pubmed:copyrightInfoCopyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21616285pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21616285pubmed:day31lld:pubmed
pubmed-article:21616285pubmed:volume57lld:pubmed
pubmed-article:21616285pubmed:ownerNLMlld:pubmed
pubmed-article:21616285pubmed:authorsCompleteYlld:pubmed
pubmed-article:21616285pubmed:pagination2244-54lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:meshHeadingpubmed-meshheading:21616285...lld:pubmed
pubmed-article:21616285pubmed:year2011lld:pubmed
pubmed-article:21616285pubmed:articleTitleFlecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.lld:pubmed
pubmed-article:21616285pubmed:affiliationDepartment of Cardiology, Heart Failure Research Center, Academic Medical Center, Amsterdam, the Netherlands.lld:pubmed
pubmed-article:21616285pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21616285pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21616285pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:21616285pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed